| 7-BROMO-3-CHLORO-1H-INDAZOLE |
7-溴-3-氯吲唑 |
885271-75-0 |
| Crizotinib |
克唑替尼 |
877399-52-5 |
| GSK-25 |
GSK-25 |
874119-56-9 |
| NVP-BGJ398 |
FGFR抑制剂(NVP-BGJ398) |
872511-34-7 |
| Trametinib |
曲美替尼 |
871700-17-3 |
| 4-Methyl-3-[[3-[2-(methylamino)-4-pyrimidinyl]-2-pyridinyl]oxy]-N-[3-(trifluoromethyl)phenyl]benzamide |
4-甲基-3-[[3-[2-(甲基氨基)-4-嘧啶基]-2-吡啶基]氧基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
870223-96-4 |
| N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide |
N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺 |
864082-47-3 |
| Danusertib |
达鲁舍替 |
827318-97-8 |
| Pyrazolo[1,5-a]pyrimidin-5(4H)-one, 7-amino- (9CI) |
7-氨基吡唑并[1,5-A]嘧啶-5(4H)-酮 |
89418-10-0 |
| Masitinib |
马赛替尼（Masitinib） |
790299-79-5 |
| Linifanib (ABT-869) |
利尼伐尼 |
796967-16-3 |
| NVP-TAE684 |
NVP-TAE684 |
761439-42-3 |
| Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate |
乙基 7-氯吡唑并[1,5-A]嘧啶-3-甲酸基酯 |
749216-54-4 |
| VX 702 |
6-[(氨基羰基)(2,6-二氟苯基)氨基]-2-(2,4-二氟苯基)-3-吡啶甲酰胺 |
745833-23-2 |
| PF-562271 |
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 |
717907-75-0 |
| N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide |
N-甲基-N-[2-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]苯基]甲磺酰胺 |
717906-29-1 |
| BX-912 |
BX-912 |
702674-56-4 |
| N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide |
N-[3-[[5-碘-4-[[3-[(2-噻吩基羰基)氨基]丙基]氨基]-2-嘧啶基]氨基]苯基]-1-吡咯烷甲酰胺 |
702675-74-9 |
| CYC-116 |
CYC-116 |
693228-63-6 |
| Neratinib |
来那替尼 |
698387-09-6 |
